II
116th CONGRESS
1st Session
S. 1785
IN THE SENATE OF THE UNITED STATES
June 11, 2019
Ms. Hassan (for herself, Mr. Cassidy, Ms. Stabenow, Mr. Cornyn, Mr. Cardin, and Mr. Young) introduced the following bill; which was read twice and referred to the Committee on Finance
A BILL
To amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.
Short title
This Act may be cited as the Fair and Accurate Medicaid Pricing Act of 2019
or the Fair AMP Act
.
Excluding authorized generic drugs from calculation of average manufacturer price under the Medicaid drug rebate program; excluding manufacturers from definition of wholesaler
In general
Subparagraph (C) of section 1927(k)(1) of the Social Security Act (42 U.S.C. 1396r–8(k)(1)) is amended—
in the subparagraph heading, by striking Inclusion
and inserting Exclusion
;
by striking a new drug application
and inserting the manufacturer's new drug application
; and
by striking inclusive
and inserting exclusive
.
Excluding manufacturers from definition of wholesaler
Section 1927(k)(11) of the Social Security Act (42 U.S.C. 1396r–8(k)(11)) is amended—
by striking manufacturers,
; and
by striking manufacturer's and
.
Effective date
The amendments made by this section shall take effect on the first day of the first fiscal quarter that begins after the date of enactment of this Act.